VYNE·92941V308·US·equity·Healthcare - Biotechnology-13D/G
VYNE (VYNE THERAPEUTICS INC) is held by 18 institutional investors as of Q1 2026. Largest holders: CITADEL ADVISORS LLC ($307,380), TWO SIGMA INVESTMENTS, LP ($254,781), GEODE CAPITAL MANAGEMENT, LLC ($192,824). Net institutional sentiment: Mixed.
See how VYNE's score breaks down across 4 SEC sources
Showing 1-20 of 22
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer